MXC Capital Limited Further Investment in IDE Group Holdings plc

MXC Capital Limited ORD NPV
[shareaholic app="share_buttons" id_name="post_below_content"]

MXC Capital Limited (LON:MXCP), the technology focused adviser and investor, announced today that it has agreed to invest a further £2.47 million in IDE Group Holdings plc by way of a subscription for 98,851,125 new ordinary shares of 2.5 pence each in the capital of IDE at a price of 2.5 pence per IDE Share.

The MXC Subscription will be made in two tranches; an initial tranche of £0.5 million which will complete upon admission of the 20,000,000 new IDE Shares to trading on AIM which is expected to occur on 1 August 2018, and a further tranche of £1.97 million, conditional upon, inter alia, the passing of the resolutions by IDE shareholders at a general meeting of IDE expected to be held on or around 20 August 2018.

Furthermore, MXC has agreed to redeem the £750,000 of loan notes it holds in IDE as announced on 30 May 2018 by way of the allotment and issue of 30,000,000 new IDE Shares, also conditional upon IDE Shareholder Approval.

The MXC Subscription forms part of a wider fundraising by IDE to raise £5 million by way of a total subscription for new IDE Shares of £3.2 million (to include the Firm MXC Subscription and the Conditional MXC Subscription) and the issue of £1.8 million convertible loan notes, convertible at 2.5 pence per IDE Share. Furthermore, IDE is undertaking an open offer for up to £0.5 million. MXC has undertaken not to take up its entitlement under the IDE Open Offer.

On 16 July 2018 IDE announced that it had been reviewing its options to address the ongoing working capital requirements of the group and the board of IDE believes that the IDE Fundraising is the best option available to IDE to re-capitalise its balance sheet and build a strong base from which to exploit the opportunities available to it. The net proceeds of the IDE Fundraising will be used to alleviate the short term cash pressures on IDE and work towards normalising its creditors.

Following the Firm MXC Subscription, MXC will hold 63,960,000 IDE Shares, representing 29.0% of the issued share capital of IDE. Following the Conditional Subscription and the MXC Redemption, MXC will hold 172,811,125 IDE Shares, representing a maximum holding of 45.6% assuming no take up of the IDE Open Offer. IDE has successfully applied for a dispensation on behalf of MXC from making a mandatory offer for IDE under Rule 9 of the City Code on Takeovers and Mergers in relation to the IDE Fundraising.

IDE is a mid-market network, cloud and IT managed services provider. Ian Smith, CEO of MXC Capital Limited, is an Executive Director of IDE and MXC Capital Markets LLP acts as financial adviser to IDE.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Argent BioPharma Ltd, formerly MGC Pharmaceuticals Limited, is a pioneering drug discovery company in the biopharmaceutical sector. Learn about their recent name change and impactful advancements in drug development.

      Search

      Search